000806.SZ

Galaxy Biomedical Investment Co., Ltd. [000806.SZ] Stock Forecast

Buy or Sell ? Support and Resistance

What is MACD and how to read it?

How RSI can help?
RSI : 000

000806.SZ Stock Summary

In the News

000806.SZ Financial details

Company Rating
Sell
Market Cap
461.96M
Income
-395.78M
Revenue
1.45B
Book val./share
-1.21
Cash/share
0.06
Dividend
-
Dividend %
-
Employees
2.03K
Optionable
No
Shortable
Yes
Earnings
31 Mar 2023
P/E
-1.17
Forward P/E
-
PEG
0.2
P/S
0.32
P/B
-0.35
P/C
-
P/FCF
-1.15
Quick Ratio
1.16
Current Ratio
1.4
Debt / Equity
-0.16
LT Debt / Equity
-0.01
-
-
EPS (TTM)
-0.36
EPS next Y
-
EPS next Q
-
EPS this Y
-64.77%
EPS next Y
-
EPS next 5Y
-
EPS last 5Y
-13.5%
Revenue last 5Y
14.95%
Revenue Q/Q
-37.2%
EPS Q/Q
-74.5%
-
-
-
-
SMA20
-
SMA50
-
SMA100
-
Inst Own
-
Inst Trans
-
ROA
-20%
ROE
36%
ROC
-0.21%
Gross Margin
35%
Oper. Margin
-14%
Profit Margin
-27%
Payout
-3%
Shs Outstand
1.1B
Shs Float
0
-
-
-
-
Target Price
-
52W Range
0.39-2.62
52W High
-
52W Low
-
RSI
-
Rel Volume
3.85
Avg Volume
8.81M
Volume
-
Perf Week
-
Perf Month
-
Perf Quarter
-
Perf Half Y
-
-
-
-
-
Beta
0.263907
-
-
Volatility
0%, 0%
Prev Close
-
Price
-
Change
-

000806.SZ Financial Performance

Yearly Fundamentals Overview

Last date of statement is 2022-12-31

Metric History 2018-12-312019-12-312020-12-312021-12-31 2022-12-31
2.02K2.02K2.02K2.02K2.02K
Revenue per share
0.690.711.011.041.39
Net income per share
-0.64-1.260.05-0.88-0.31
Operating cash flow per share
-0.330.060.04-0.02-0.03
Free cash flow per share
-0.340.050.02-0.04-0.04
Cash per share
00.040.120.020.07
Book value per share
1.260.020.06-0.81-1.14
Tangible book value per share
1.15-0.1-0.05-0.92-1.23
Share holders equity per share
1.260.020.06-0.81-1.14
Interest debt per share
0.540.220.160.120.2
Market cap
4.36B2.49B1.84B2.91B1.94B
Enterprise value
4.84B2.57B1.89B2.95B2.06B
P/E ratio
-6.17-1.831.51-3.01-5.75
Price to sales ratio
5.723.181.662.551.27
POCF ratio
-11.9639.3341.11-106.93-56.9
PFCF ratio
-11.5248.0270.5-59.11-47.22
P/B Ratio
3.14103.1727.46-3.29-1.54
PTB ratio
3.14103.1727.46-3.29-1.54
EV to sales
6.353.291.712.581.35
Enterprise value over EBITDA
-28.15-8.113.6727.497.74
EV to operating cash flow
-13.2740.6342.2-108.22-60.44
EV to free cash flow
-12.7849.672.36-59.83-50.16
Earnings yield
-0.16-0.560.03-0.33-0.17
Free cash flow yield
-0.090.020.01-0.02-0.02
Debt to equity
0.387.562.37-0.14-0.16
Debt to assets
0.210.110.070.070.1
Net debt to EBITDA
-2.79-0.260.350.330.45
Current ratio
1.660.881.331.411.4
Interest coverage
-10.85-1.655.444.1211.56
Income quality
0.49-0.050.720.030.1
Dividend Yield
0.010.01000
Payout ratio
-0.05-0.010.140-0.01
Sales general and administrative to revenue
0.080.070.030.070.02
Research and developement to revenue
0.130.050.030.050.05
Intangibles to total assets
0.050.070.060.070.06
Capex to operating cash flow
0.04-0.18-0.420.810.21
Capex to revenue
-0.02-0.01-0.02-0.020
Capex to depreciation
-0.31-0.36-0.66-0.46-0.15
Stock based compensation to revenue
00000
Graham number
4.270.790.273.992.8
ROIC
-0.39-0.520.36-0.08-0.23
Return on tangible assets
-0.3-0.870.03-0.6-0.18
Graham Net
0.07-0.91-0.87-1.73-1.99
Working capital
679.55M-150.8M380.85M331.4M419.22M
Tangible asset value
1.26B-106.98M-58.64M-1.01B-1.36B
Net current asset value
624.6M-636.27M-543.95M-1.5B-1.79B
Invested capital
0.387.562.37-0.14-0.16
Average receivables
1.31B1.06B921.13M952.79M968.42M
Average payables
280.48M302.77M321.94M282.54M273.18M
Average inventory
356.46M244.87M246.48M256.97M240.06M
Days sales outstanding
678.04325.13378.27242.27281.26
Days payables outstanding
160.61218.8153.99132.62105.7
Days of inventory on hand
139.14167.11118.21142.5373.95
Receivables turnover
0.541.120.961.511.3
Payables turnover
2.271.672.372.753.45
Inventory turnover
2.622.183.092.564.94
ROE
-0.51-57.390.871.090.27
Capex per share
-0.01-0.01-0.02-0.02-0.01

Quarterly Fundamentals Overview

Last date of statement is 2023-03-31 for Q1

Metric History 2022-03-312022-06-302022-09-302022-12-31 2023-03-31
2.02K2.02K2.02K2.02K2.02K
Revenue per share
0.290.410.320.360.22
Net income per share
-0.010.01-0.04-0.26-0.07
Operating cash flow per share
-0.030.01-0.04-0.26-0.07
Free cash flow per share
-0.030.01-0.04-0.26-0.07
Cash per share
0.060.050.050.070.06
Book value per share
-0.82-0.83-0.87-1.14-1.21
Tangible book value per share
-0.93-0.92-0.96-1.23-1.3
Share holders equity per share
-0.82-0.83-0.87-1.14-1.21
Interest debt per share
0.110.120.120.190.2
Market cap
2.25B2.48B2.33B1.94B1.26B
Enterprise value
2.31B2.55B2.4B2.06B1.41B
P/E ratio
-39.6171.59-13.65-1.67-4.34
Price to sales ratio
6.995.426.544.945.13
POCF ratio
-70.14286.38-54.58-6.7-17.34
PFCF ratio
-66.73382.56-52.76-6.66-17.14
P/B Ratio
-2.5-2.72-2.43-1.54-0.95
PTB ratio
-2.5-2.72-2.43-1.54-0.95
EV to sales
7.165.586.755.245.73
Enterprise value over EBITDA
45.827.9945.7483.83133.22
EV to operating cash flow
-71.87294.57-56.31-7.12-19.37
EV to free cash flow
-68.38393.5-54.43-7.08-19.15
Earnings yield
-0.010-0.02-0.15-0.06
Free cash flow yield
-0.010-0.02-0.15-0.06
Debt to equity
-0.13-0.14-0.13-0.16-0.16
Debt to assets
0.070.070.070.10.11
Net debt to EBITDA
1.110.781.44.9113.99
Current ratio
1.411.431.461.41.4
Interest coverage
17.2820.4912.22-37.23-14.58
Income quality
2.191111
Dividend Yield
00000
Payout ratio
-0.140.21-0.12-0.01-0.04
Sales general and administrative to revenue
0.1-0.040.23-0.150.14
Research and developement to revenue
0.040.030.030.080.06
Intangibles to total assets
0.070.070.060.060.06
Capex to operating cash flow
0.05-0.250.030.010.01
Capex to revenue
-0.010000
Capex to depreciation
00000
Stock based compensation to revenue
00000
Graham number
0.490.380.872.61.34
ROIC
-0.17-0.05-0.080.270.06
Return on tangible assets
-0.010.01-0.03-0.15-0.04
Graham Net
-1.66-1.65-1.69-1.99-2.07
Working capital
319.11M352.02M391.14M419.22M421.73M
Tangible asset value
-1.02B-1.02B-1.06B-1.36B-1.43B
Net current asset value
-1.51B-1.49B-1.51B-1.79B-1.86B
Invested capital
-0.13-0.14-0.13-0.16-0.16
Average receivables
764.02M831.22M924.05M1.07B1.16B
Average payables
250.92M246.62M254.99M271.47M292.14M
Average inventory
271.1M235.22M222.06M217.5M225.61M
Days sales outstanding
214.84175.72241.22270.22417.08
Days payables outstanding
103.7676.23103.41101159.75
Days of inventory on hand
112.7463.0494.570.65134.46
Receivables turnover
0.420.510.370.330.22
Payables turnover
0.871.180.870.890.56
Inventory turnover
0.81.430.951.270.67
ROE
0.02-0.010.040.230.05
Capex per share
00000

000806.SZ Frequently Asked Questions

What is Galaxy Biomedical Investment Co., Ltd. stock symbol ?

Galaxy Biomedical Investment Co., Ltd. is a CN stock and trading under the symbol 000806.SZ

What is Galaxy Biomedical Investment Co., Ltd. stock quote today ?

Galaxy Biomedical Investment Co., Ltd. stock price is $- today.

Is Galaxy Biomedical Investment Co., Ltd. stock public?

Yes, Galaxy Biomedical Investment Co., Ltd. is a publicly traded company.

Something similar